Judge Proceeds with Risperdal Punitive Damages Trial
Philadelphia Court of Common Pleas Judge Arnold L. New has ordered two Risperdal cases to proceed in a new trial for punitive damages. In both cases, causation and compensatory damage were already awarded the plaintiffs– Stange v. Janssen Pharmaceuticals ($500,000) and Murray v. Janssen Pharmaceuticals ($1.75M later reduced to $680,000). Judge New previously ruled in agreement […]
PA Supreme Court Will Hear Appeal of Risperdal Time-Bar
The PA Supreme Court has agreed to review a Superior Court decision which would dismiss thousands of Risperdal cases due to statute of limitations. The two cases on appeal, Saksek v. Janssen and Winter v. Janssen, were dismissed for failing to bring a claim with in the applicable two year statue of limitations. The Supreme Court’s decision would […]
Superior Court Allows Punitive Damages in Risperdal Mass Torts
In a significant ruling by the Pennsylvania Superior Court, Janssen, a subsidiary of Johnson & Johnson (J&J), will now face punitive damages in Risperdal mass tort suits. A previous Philadelphia trial court ruling prohibited punitive damages. Boys and young men who developed gynecomastia, female-like breasts, from taking the antipsychotic drug and whose cases had already […]
Sheller hits #1 Top 50 Verdicts in Pennsylvania for 2016
Sheller PC’s $70 Million Risperdal win hits #1 on the Top 50 Verdicts in Pennsylvania in 2016. In the case A.Y., Pro Ami v. Janssen Pharmaceuticals, Inc., a jury found for an autistic Tennessee boy who grew female-like breasts after taking the antipsychotic drug Rispderal. The unprecedented $70 Million verdict in damages for physical disfigurement and emotional […]
High Court Won’t Hear Sheller Dispute with FDA over Risperdal
High Court Won’t Hear Dispute Challenging FDA Over J&J Drug Supreme Court won’t weigh in on whether law firm can sue FDA over drug labeling Circumstances in which third parties can sue over government actions remain unclear By Dana A. Elfin A Philadelphia-based law firm has hit the end of the road in its bid […]
Researchers Concerned About Over-Prescription of Risperdal
The most recent study published on the use of antipsychotics, such as Risperdal, Zyprexa and Seroquel, in children with ADHD has researchers concerned that there may be an over-prescription problem. The study published January 19, 2017 in The Canadian Journal of Psychiatry shows the same dramatic increase in use of antipsychotics prescribed off-label in children with ADHD, ages 1 […]
$70M Risperdal Verdict
In the Philly Inquirer July 2, 2016: Philadelphia jury pins $70m verdict on Janssen for its Risperdal drug A Philadelphia jury found Friday that the antipsychotic drug Risperdal caused a Tennessee boy to grow breasts and imposed a $70 million verdict on its manufacturer, Janssen Pharmaceuticals. Lawyers for the boy argued that scientists for the […]
Sheller Appears on “Full Measure” TV
Attorney Stephen Sheller appeared on the television program “Full Measure’ May 1, 2016 discussing Risperdal gynecomastia cases. Sheller was interviewed by Sharyl Attkisson, who previously covered the Risperdal story with attorney Sheller for CBS news, in a video that has now been watched nearly 60,000 times on the CBS and Sheller YouTube channels. Full Measure is the […]
Sheller Risperdal Fight, Philadelphia Weekly
Stephen Sheller is regarded as the “Legal Forest Gump” by Liz Spikol, Philadelphia Weekly, in the article “Mind Control”, a story that reveals raw, unconcealed experience with antipsychotic drugs like Risperdal and poses a key question – why are we giving antipsychotic drugs to thousands of kids who don’t even need them? “Philadelphia is ground zero for much of […]
Plaintiffs 3-for-4 in Philadelphia Risperdal trials
Plaintiffs 3-for-4 in Philadelphia Risperdal trials, confident punitive damages will be reintroduced If the results of the first trials are any indication, Janssen Pharmaceuticals might find itself with a hefty price tag connected to more than 1,600 Risperdal cases currently pending in Philadelphia, even without the prospect of paying punitive damages – though an appeal […]
